Sofinnova Investments’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-791,667
| Closed | -$5.23M | – | 66 |
|
|
2025
Q1 | $5.23M | Buy |
+791,667
| New | +$5.23M | 0.34% | 47 |
|
|
2024
Q4 | – | Sell |
-296,884
| Closed | -$5.8M | – | 68 |
|
|
2024
Q3 | $5.8M | Sell |
296,884
-528,359
| -64% | -$10.3M | 0.46% | 37 |
|
|
2024
Q2 | $17M | Buy |
825,243
+323,303
| +64% | +$6.66M | 0.88% | 30 |
|
|
2024
Q1 | $10.7M | Sell |
501,940
-1,165,381
| -70% | -$24.9M | 0.6% | 36 |
|
|
2023
Q4 | $24M | Buy |
+1,667,321
| New | +$24M | 1.34% | 20 |
|
|
2023
Q2 | – | Sell |
-616,169
| Closed | -$7.54M | – | 54 |
|
|
2023
Q1 | $7.54M | Buy |
616,169
+22,608
| +4% | +$276K | 0.48% | 35 |
|
|
2022
Q4 | $7.37M | Buy |
+593,561
| New | +$7.37M | 0.44% | 32 |
|
|
2022
Q1 | – | Sell |
-369,173
| Closed | -$5.17M | – | 67 |
|
|
2021
Q4 | $5.17M | Sell |
369,173
-385,948
| -51% | -$5.4M | 0.3% | 50 |
|
|
2021
Q3 | $14.1M | Buy |
755,121
+310,749
| +70% | +$5.82M | 0.84% | 28 |
|
|
2021
Q2 | $9.27M | Buy |
444,372
+361,208
| +434% | +$7.53M | 0.53% | 39 |
|
|
2021
Q1 | $2.35M | Sell |
83,164
-37,513
| -31% | -$1.06M | 0.14% | 56 |
|
|
2020
Q4 | $3.94M | Sell |
120,677
-104,582
| -46% | -$3.42M | 0.23% | 51 |
|
|
2020
Q3 | $6.9M | Sell |
225,259
-385,720
| -63% | -$11.8M | 0.51% | 31 |
|
|
2020
Q2 | $9.96M | Buy |
+610,979
| New | +$9.96M | 0.63% | 32 |
|
|
2018
Q4 | – | Sell |
-247,385
| Closed | -$4.33M | – | 66 |
|
|
2018
Q3 | $4.33M | Buy |
247,385
+79,485
| +47% | +$1.39M | 0.39% | 40 |
|
|
2018
Q2 | $3.06M | Buy |
+167,900
| New | +$3.06M | 0.35% | 45 |
|